Mineralys Therapeutics Reports Second Quarter 2023 Financial Results, Provides Corporate Update
RADNOR, PA — Mineralys Therapeutics, Inc. (Nasdaq: MLYS), a clinical-stage biopharmaceutical company, this week announced financial results for the quarter ending June 30, 2023, and provided a corporate update.
Mineralys Therapeutics Reports Second Quarter 2023 Financial Results, Provides Corporate Update Read More